Review article · 2022 · Open access

Recent Advances in Lipid Nanoparticles for Delivery of mRNA

Lei Yang, Liming Gong, Ping Wang, Xinghui Zhao, Feng Hua Zhao, Zhijie Zhang, Yunfei Li, Wei Huang

Pharmaceutics, 14(12), 2682 · Published 1 December 2022 · DOI 10.3390/pharmaceutics14122682

Open PDFView at the publisherCite this paper

In brief

“Recent Advances in Lipid Nanoparticles for Delivery of mRNA” is a 2022 review article by Lei Yang and 7 co-authors, published in Pharmaceutics. OpenAlex counts 203 citations as of 21 November 2026, which puts it in the top 1% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.

Citations
203
Most cited in
2025 (78)
Field-weighted impact
3.33
References
192
Authors
8

Abstract

Messenger RNA (mRNA), which is composed of ribonucleotides that carry genetic information and direct protein synthesis, is transcribed from a strand of DNA as a template. On this basis, mRNA technology can take advantage of the body's own translation system to express proteins with multiple functions for the treatment of various diseases. Due to the advancement of mRNA synthesis and purification, modification and sequence optimization technologies, and the emerging lipid nanomaterials and other delivery systems, mRNA therapeutic regimens are becoming clinically feasible and exhibit significant reliability in mRNA stability, translation efficiency, and controlled immunogenicity. Lipid nanoparticles (LNPs), currently the leading non-viral delivery vehicles, have made many exciting advances in clinical translation as part of the COVID-19 vaccines and therefore have the potential to accelerate the clinical translation of gene drugs. Additionally, due to their small size, biocompatibility, and biodegradability, LNPs can effectively deliver nucleic acids into cells, which is particularly important for the current mRNA regimens. Therefore, the cutting-edge LNP@mRNA regimens hold great promise for cancer vaccines, infectious disease prevention, protein replacement therapy, gene editing, and rare disease treatment. To shed more lights on LNP@mRNA, this paper mainly discusses the rational of choosing LNPs as the non-viral vectors to deliver mRNA, the general rules for mRNA optimization and LNP preparation, and the various parameters affecting the delivery efficiency of LNP@mRNA, and finally summarizes the current research status as well as the current challenges. The latest research progress of LNPs in the treatment of other diseases such as oncological, cardiovascular, and infectious diseases is also given. Finally, the future applications and perspectives for LNP@mRNA are generally introduced.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yang, L., Gong, L., Wang, P., Zhao, X., Zhao, F. H., Zhang, Z., Li, Y., & Huang, W. (2022). Recent Advances in Lipid Nanoparticles for Delivery of mRNA. Pharmaceutics, 14(12), 2682. https://doi.org/10.3390/pharmaceutics14122682

MLA 9

Yang, Lei, et al. “Recent Advances in Lipid Nanoparticles for Delivery of mRNA.” Pharmaceutics, vol. 14, no. 12, 2022, p. 2682. https://doi.org/10.3390/pharmaceutics14122682.

Chicago

Yang, Lei, Liming Gong, Ping Wang, Xinghui Zhao, Feng Hua Zhao, Zhijie Zhang, Yunfei Li, and Wei Huang. 2022. “Recent Advances in Lipid Nanoparticles for Delivery of mRNA.” Pharmaceutics 14 (12): 2682. https://doi.org/10.3390/pharmaceutics14122682.

Harvard

Yang, L. et al. (2022) ‘Recent Advances in Lipid Nanoparticles for Delivery of mRNA’, Pharmaceutics, 14(12), p. 2682. doi:10.3390/pharmaceutics14122682.

IEEE

L. Yang et al., “Recent Advances in Lipid Nanoparticles for Delivery of mRNA,” Pharmaceutics, vol. 14, no. 12, p. 2682, 2022, doi: 10.3390/pharmaceutics14122682.

BibTeX

@article{yang2022recent,
  title     = {{Recent Advances in Lipid Nanoparticles for Delivery of mRNA}},
  author    = {Yang, Lei and Gong, Liming and Wang, Ping and Zhao, Xinghui and Zhao, Feng Hua and Zhang, Zhijie and Li, Yunfei and Huang, Wei},
  journal   = {Pharmaceutics},
  year      = {2022},
  volume    = {14},
  number    = {12},
  pages     = {2682},
  doi       = {10.3390/pharmaceutics14122682},
  url       = {https://doi.org/10.3390/pharmaceutics14122682}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20231515
20244545
20257878
20266565

Its field-weighted citation impact is 3.33: it has been cited 3.33 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • mRNA delivery
  • non-viral vectors
  • mRNA vaccines
  • COVID-19 vaccines
  • delivery efficiency
  • cancer vaccines
  • genome editing

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Yang, L., Gong, L., Wang, P., Zhao, X., Zhao, F. H., Zhang, Z., Li, Y., & Huang, W. (2022). Recent Advances in Lipid Nanoparticles for Delivery of mRNA. Pharmaceutics, 14(12), 2682. https://doi.org/10.3390/pharmaceutics14122682

How many times has this paper been cited?

203 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmaceutics: sign in and open the PDF from this page.

Who wrote this paper?

Lei Yang, Liming Gong, Ping Wang, Xinghui Zhao, Feng Hua Zhao, Zhijie Zhang, Yunfei Li, Wei Huang.

What is the DOI of this paper?

10.3390/pharmaceutics14122682, permanently at https://doi.org/10.3390/pharmaceutics14122682. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.